%Start Pfizer sets new prices for its COVID-19 vaccines The cost $110 to $130 per dose Article_Normal - Biotechnology HEAD TOPICS
Pfizer sets new prices for its COVID-19 vaccines The cost $110 to $130 per dose
10/21/2022 5:55:00 PM
The company plans to sell the COVID-19 shot it developed with BioNTech for $110 to $130 per dose once the U S market for COVID-19 shots becomes commercial
Article_Normal Biotechnology
Source
MarketWatch
Pfizer and BioNTech are currently paid $30.50 per COVID vaccine dose by the U.S. government. The price will skyrocket if the emergency declaration in the U.S.
thumb_upLike (2)
commentReply (2)
shareShare
visibility958 views
thumb_up2 likes
comment
2 replies
E
Ella Rodriguez 2 minutes ago
isn’t renewed next year. The company plans to sell the COVID-19 shot it developed with BioNTech fo...
A
Audrey Mueller 2 minutes ago
government, which contracted with the companies (as well as other vaccine makers like Moderna Inc. M...
A
Andrew Wilson Member
access_time
10 minutes ago
Wednesday, 07 May 2025
isn’t renewed next year. The company plans to sell the COVID-19 shot it developed with BioNTech for $110 to $130 per dose once the U S market for COVID-19 shots becomes commercial
Pfizer and BioNTech are currently paid $30.50 per vaccine dose by the U.S.
thumb_upLike (18)
commentReply (2)
thumb_up18 likes
comment
2 replies
S
Sophie Martin 7 minutes ago
government, which contracted with the companies (as well as other vaccine makers like Moderna Inc. M...
E
Emma Wilson 9 minutes ago
NVAX, +6.46% ) and then made the COVID-19 shots available at no cost to people in the U.S. during th...
N
Noah Davis Member
access_time
15 minutes ago
Wednesday, 07 May 2025
government, which contracted with the companies (as well as other vaccine makers like Moderna Inc. MRNA, +7.07% and Novavax Inc.
thumb_upLike (38)
commentReply (2)
thumb_up38 likes
comment
2 replies
W
William Brown 9 minutes ago
NVAX, +6.46% ) and then made the COVID-19 shots available at no cost to people in the U.S. during th...
J
James Smith 5 minutes ago
The emergency declaration in the U.S. isn’t expected to be renewed next year, which will lead to t...
N
Natalie Lopez Member
access_time
8 minutes ago
Wednesday, 07 May 2025
NVAX, +6.46% ) and then made the COVID-19 shots available at no cost to people in the U.S. during the public-health emergency.
thumb_upLike (47)
commentReply (2)
thumb_up47 likes
comment
2 replies
O
Oliver Taylor 7 minutes ago
The emergency declaration in the U.S. isn’t expected to be renewed next year, which will lead to t...
S
Sofia Garcia 8 minutes ago
Read more: MarketWatch » Pfizer Targets Covid Vaccine Price of at Least $110 a Dose FDA aut...
E
Emma Wilson Admin
access_time
10 minutes ago
Wednesday, 07 May 2025
The emergency declaration in the U.S. isn’t expected to be renewed next year, which will lead to the formation of an official commercial market for COVID-19 vaccines, tests and treatments. That said, this change doesn’t mean most Americans will be on the hook to pay for their shots in 2023 and beyond.
thumb_upLike (26)
commentReply (0)
thumb_up26 likes
D
Dylan Patel Member
access_time
12 minutes ago
Wednesday, 07 May 2025
Read more: MarketWatch » Pfizer Targets Covid Vaccine Price of at Least $110 a Dose FDA authorizes Novavax's Covid shots as mix-and-match booster to Pfizer or Moderna Labour board finds Sask. professor was wrongly disciplined over COVID-19 posts The City of Dallas May Offer Eviction Protections Beyond COVID-19 Pandemic
Today in History October 21 Edison perfects electric light
Read more >> The additional $80 pays for lawsuits? why is cost tied to “emergency” status?
thumb_upLike (49)
commentReply (2)
thumb_up49 likes
comment
2 replies
O
Oliver Taylor 7 minutes ago
Pfizer Targets Covid Vaccine Price of at Least $110 a DosePfizer said it expects to price its Covid-...
M
Mason Rodriguez 9 minutes ago
I'm interested in how much Novavax will be. They have been working on a new strain of Covid?...
C
Charlotte Lee Member
access_time
7 minutes ago
Wednesday, 07 May 2025
Pfizer Targets Covid Vaccine Price of at Least $110 a DosePfizer said it expects to price its Covid-19 vaccine at $110 to $130 a dose for adults when the U.S. government stops purchases Talk about deterrence.
thumb_upLike (50)
commentReply (3)
thumb_up50 likes
comment
3 replies
I
Isabella Johnson 2 minutes ago
I'm interested in how much Novavax will be. They have been working on a new strain of Covid?...
H
Hannah Kim 1 minutes ago
Because this “vaccine” is worthless. FDA authorizes Novavax's Covid shots as mix-and-match b...
I'm interested in how much Novavax will be. They have been working on a new strain of Covid?
thumb_upLike (6)
commentReply (0)
thumb_up6 likes
C
Christopher Lee Member
access_time
36 minutes ago
Wednesday, 07 May 2025
Because this “vaccine” is worthless. FDA authorizes Novavax's Covid shots as mix-and-match booster to Pfizer or ModernaNovavax's Covid shots rely on protein technology used in other vaccines for decades, rather than the messenger RNA used in the Pfizer and Moderna vaccines.
thumb_upLike (36)
commentReply (2)
thumb_up36 likes
comment
2 replies
A
Amelia Singh 34 minutes ago
It's all a weird game, no single expert got problems with Novavax vaccine. Vaccine is safe for a...
J
Julia Zhang 2 minutes ago
Moderna and Pfizer J&J ain't that safe as the company's claim. Google it yourself....
T
Thomas Anderson Member
access_time
30 minutes ago
Wednesday, 07 May 2025
It's all a weird game, no single expert got problems with Novavax vaccine. Vaccine is safe for all ages and efficient.
thumb_upLike (19)
commentReply (0)
thumb_up19 likes
S
Sophie Martin Member
access_time
33 minutes ago
Wednesday, 07 May 2025
Moderna and Pfizer J&J ain't that safe as the company's claim. Google it yourself.
thumb_upLike (16)
commentReply (3)
thumb_up16 likes
comment
3 replies
I
Isaac Schmidt 16 minutes ago
Novavax = safe and efficient HARD PASS
Labour board finds Sask. professor was wrongly disciplined ov...
N
Natalie Lopez 25 minutes ago
I’ve seen ironclad legalese to cover this 😂 Dr. Kyle. What a Covid obsessed sack of trash ...
Novavax = safe and efficient HARD PASS
Labour board finds Sask. professor was wrongly disciplined over COVID-19 postsAn arbitrator has ruled that the University of Saskatchewan never should have sent a letter telling an outspoken faculty member to remove references to his employment from his social media accounts DrKyle good to hear, unfortunate you had to go through this. Sounds like they need a better social media policy.
thumb_upLike (31)
commentReply (0)
thumb_up31 likes
C
Christopher Lee Member
access_time
65 minutes ago
Wednesday, 07 May 2025
I’ve seen ironclad legalese to cover this 😂 Dr. Kyle. What a Covid obsessed sack of trash he is.
thumb_upLike (1)
commentReply (2)
thumb_up1 likes
comment
2 replies
A
Ava White 6 minutes ago
The City of Dallas May Offer Eviction Protections Beyond COVID-19 PandemicThe conditions under which...
C
Christopher Lee 63 minutes ago
Yikes. Big reason: far right messaging. Republican candidates are pushing crazy cures and disparagin...
K
Kevin Wang Member
access_time
42 minutes ago
Wednesday, 07 May 2025
The City of Dallas May Offer Eviction Protections Beyond COVID-19 PandemicThe conditions under which Dallas’ COVID-19 eviction ordinance were created don’t really exist today. That's why the city is looking for a new ordinance. Whites now more likely to die from covid than Blacks: Why the pandemic shiftedAs the pandemic progressed, the damage done by the coronavirus broadened, and the toxicity of modern-day politics came to the fore.
thumb_upLike (47)
commentReply (2)
thumb_up47 likes
comment
2 replies
D
David Cohen 16 minutes ago
Yikes. Big reason: far right messaging. Republican candidates are pushing crazy cures and disparagin...
M
Mason Rodriguez 13 minutes ago
Facebook-sponsored vaccine disinfo hits white people more. Pfizer Inc.The drugmaker laid out a poten...
A
Audrey Mueller Member
access_time
45 minutes ago
Wednesday, 07 May 2025
Yikes. Big reason: far right messaging. Republican candidates are pushing crazy cures and disparaging effective vaccines.
thumb_upLike (33)
commentReply (3)
thumb_up33 likes
comment
3 replies
A
Andrew Wilson 23 minutes ago
Facebook-sponsored vaccine disinfo hits white people more. Pfizer Inc.The drugmaker laid out a poten...
N
Nathan Chen 39 minutes ago
PFE, +4.08% said Thursday that it plans to sell the COVID-19 shot it developed with BioNTech SE BNTX...
Facebook-sponsored vaccine disinfo hits white people more. Pfizer Inc.The drugmaker laid out a potential price as it prepares to sell the shot commercially, perhaps early next year Pfizer said the earliest there could be a commercial rollout would be early next year.WATCH LIVE Key Points The FDA has authorized a third dose of Novavax's Covid vaccine for adults ages 18 and older.Back to video Lawyer Eric Cline presided over the labour board hearing between the university and its faculty association, which acted on behalf of Kyle Anderson, a tenured assistant professor in the College of Medicine’s department of biochemistry, microbiology and immunology.
thumb_upLike (41)
commentReply (2)
thumb_up41 likes
comment
2 replies
T
Thomas Anderson 2 minutes ago
PFE, +4.08% said Thursday that it plans to sell the COVID-19 shot it developed with BioNTech SE BNTX...
J
Julia Zhang 45 minutes ago
market for COVID-19 shots becomes commercial, likely in the first quarter of next year. You may unsu...
E
Elijah Patel Member
access_time
85 minutes ago
Wednesday, 07 May 2025
PFE, +4.08% said Thursday that it plans to sell the COVID-19 shot it developed with BioNTech SE BNTX, +8. Hopkins Oct.33% for $110 to $130 per dose once the U.5, according to the company.S. gave some details about its plans to sell the Covid-19 vaccine it developed with BioNTech SE on the commercial market in the U.
thumb_upLike (47)
commentReply (0)
thumb_up47 likes
M
Mia Anderson Member
access_time
36 minutes ago
Wednesday, 07 May 2025
market for COVID-19 shots becomes commercial, likely in the first quarter of next year. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails.
thumb_upLike (29)
commentReply (1)
thumb_up29 likes
comment
1 replies
H
Hannah Kim 6 minutes ago
Pfizer and BioNTech are currently paid $30., saying it expects to price the shot at $110 to $130 per...
J
Joseph Kim Member
access_time
57 minutes ago
Wednesday, 07 May 2025
Pfizer and BioNTech are currently paid $30., saying it expects to price the shot at $110 to $130 per dose for adults. Hannah Beier Bloomberg Getty Images The Food and Drug Administration has authorized Novavax's Covid boosters for adults in the U.50 per vaccine dose by the U.S.
thumb_upLike (47)
commentReply (2)
thumb_up47 likes
comment
2 replies
M
Madison Singh 44 minutes ago
Continue reading your article with a WSJ membership. government, which contracted with the companies...
S
Scarlett Brown 30 minutes ago
MRNA, +7. We encountered an issue signing you up. 07% and Novavax Inc....
D
Dylan Patel Member
access_time
100 minutes ago
Wednesday, 07 May 2025
Continue reading your article with a WSJ membership. government, which contracted with the companies (as well as other vaccine makers like Moderna Inc. The authorization of Novavax's booster could significantly increase the role that its shot plays in U.
thumb_upLike (18)
commentReply (1)
thumb_up18 likes
comment
1 replies
T
Thomas Anderson 34 minutes ago
MRNA, +7. We encountered an issue signing you up. 07% and Novavax Inc....
J
Julia Zhang Member
access_time
84 minutes ago
Wednesday, 07 May 2025
MRNA, +7. We encountered an issue signing you up. 07% and Novavax Inc.
thumb_upLike (8)
commentReply (3)
thumb_up8 likes
comment
3 replies
H
Henry Schmidt 60 minutes ago
NVAX, +6. Up until now, Novavax's vaccine was only authorized as a two-dose primary series, whic...
B
Brandon Kumar 9 minutes ago
during the public-health emergency. "According to CDC data, almost 50 percent of adults who rec...
NVAX, +6. Up until now, Novavax's vaccine was only authorized as a two-dose primary series, which limited its market because so many people were already immunized with Pfizer of Moderna.46% ) and then made the COVID-19 shots available at no cost to people in the U.S.
thumb_upLike (28)
commentReply (2)
thumb_up28 likes
comment
2 replies
L
Liam Wilson 54 minutes ago
during the public-health emergency. "According to CDC data, almost 50 percent of adults who rec...
T
Thomas Anderson 37 minutes ago
The emergency declaration in the U.S. isn’t expected to be renewed next year, which will lead to t...
I
Isabella Johnson Member
access_time
69 minutes ago
Wednesday, 07 May 2025
during the public-health emergency. "According to CDC data, almost 50 percent of adults who received their primary series have yet to receive their first booster dose. He was also getting favourable notes from his supervisors, and being tapped to do interviews when media called the university with questions about COVID-19.
thumb_upLike (41)
commentReply (0)
thumb_up41 likes
L
Lucas Martinez Moderator
access_time
120 minutes ago
Wednesday, 07 May 2025
The emergency declaration in the U.S. isn’t expected to be renewed next year, which will lead to the formation of an official commercial market for COVID-19 vaccines, tests and treatments.1, BA. That said, this change doesn’t mean most Americans will be on the hook to pay for their shots in 2023 and beyond.
thumb_upLike (37)
commentReply (3)
thumb_up37 likes
comment
3 replies
W
William Brown 48 minutes ago
A recent Kaiser Family Foundation analysis said most people with private insurance won’t be expect...
N
Noah Davis 83 minutes ago
The booster dose also induced an immune response in participants who received Moderna, Pfizer and Jo...
A recent Kaiser Family Foundation analysis said most people with private insurance won’t be expected to pay anything out of pocket for the vaccines, though the costs may eventually be baked into the price of health-insurance premiums, as is done with flu shots. This led the RCMP to question Anderson to ensure there was no threat to Moe’s safety. People with Medicare will have their shots covered by Medicare Part B, while those with Medicaid should also have coverage of COVID-19 vaccines.
thumb_upLike (27)
commentReply (0)
thumb_up27 likes
J
Jack Thompson Member
access_time
104 minutes ago
Wednesday, 07 May 2025
The booster dose also induced an immune response in participants who received Moderna, Pfizer and Johnson & Johnson as their primary series, according to the company. It’s the uninsured who may find it difficult to find free vaccines and boosters in the future.
thumb_upLike (3)
commentReply (0)
thumb_up3 likes
N
Nathan Chen Member
access_time
54 minutes ago
Wednesday, 07 May 2025
Wall Street analysts cheered the news, saying Pfizer’s pricing plan came in above expectations. It also bodes well for Moderna’s stock.
thumb_upLike (43)
commentReply (0)
thumb_up43 likes
A
Audrey Mueller Member
access_time
84 minutes ago
Wednesday, 07 May 2025
"These data are an early indication that our vaccine may be effective against variants such as Omicron. SVB Securities upgraded the company to market perform from underperform, though the company has not yet announced its pricing plans for its COVID-19 shots. The grievance before Cline concerned a letter sent to Anderson after the April 22 tweet, signed by the university’s president, vice-president academic and the dean of the College of Medicine.
thumb_upLike (30)
commentReply (1)
thumb_up30 likes
comment
1 replies
S
Sophie Martin 5 minutes ago
“Presuming that MRNA prices as a rational duopolist, this substantially improves the company’s a...
C
Christopher Lee Member
access_time
87 minutes ago
Wednesday, 07 May 2025
“Presuming that MRNA prices as a rational duopolist, this substantially improves the company’s ability to meet 2023 revenue guidance,” SVB analyst Mani Foroohar told investors. .
thumb_upLike (33)
commentReply (3)
thumb_up33 likes
comment
3 replies
E
Evelyn Zhang 23 minutes ago
Pfizer's and Moderna's also carry an elevated risk of myocarditis primarily in young men and...
D
Daniel Kumar 57 minutes ago
Pfizer sets new prices for its COVID-19 vaccines The cost $110 to $130 per dose Article_Normal - ...